갱년기 장애 치료 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 의료 인프라 투자 증가, 여성 건강 프로그램에 대한 집중 강화, 제약 회사와 연구 기관 간의 협력 확대, 도시화 가속화로 인한 생활 방식 변화가 갱년기 건강에 미치는 영향 등이 주요 요인으로 꼽힙니다. 이 기간에 예상되는 주요 동향으로는 천연 및 한방 치료 옵션으로의 전환, 치료 계획에 인공 지능의 통합, 실시간 증상 추적을 위한 웨어러블 기기의 등장, 갱년기를 다루는 전체론적 웰니스 프로그램에 대한 강조, 갱년기 관련 솔루션을 개발하는 여성 건강 스타트업에 대한 투자 증가 등이 있습니다.
호르몬 대체 요법(HRT)에 대한 수요가 증가하면서 갱년기 장애 치료 시장이 확대될 것으로 예상됩니다. HRT는 갱년기이나 호르몬 불균형으로 인한 증상을 완화하기 위해 호르몬을 보충하거나 대체하는 의학적 치료법입니다. HRT 사용의 증가는 주로 갱년기 증상과 호르몬 불균형의 효과적인 관리에 대한 인식과 수요가 증가함에 따라 촉진되고 있습니다. HRT는 에스트로겐과 프로게스테론 수치를 보충하여 호르몬 균형을 회복하고 일과성 열감, 야간 발한, 기분 변화와 같은 불쾌한 증상을 완화하여 갱년기 장애를 치료함으로써 삶의 질을 향상시킵니다. 예를 들어, 2024년 10월, 다양한 지원 서비스를 제공하는 영국 기반 기관인 NHS Business Services Authority(NHSBSA)는 HRT 처방이 22% 증가하여 1,300만 건에 달했다고 보고했습니다. 또한 HRT로 확인된 환자 수는 2022/23년 230만 명에서 2023/24년 260만 명으로 12% 증가했습니다. 호르몬 대체 요법에 대한 이러한 수요 증가는 갱년기 장애 치료제 시장의 성장에 기여하고 있습니다.
갱년기 장애 치료제 시장의 선도 기업들은 호르몬을 사용하지 않고 혈관 운동 증상을 효과적으로 관리하기 위해 신경 키닌 3(NK3) 수용체 길항제 약물과 같은 첨단 비호르몬 요법을 개발하고 있습니다. 이러한 새로운 요법은 NK3 수용체를 차단하여 갱년기 증상을 관리함으로써 전통적인 호르몬 치료의 대안을 제공합니다. 예를 들어, 2023년 12월 일본에 본사를 두고 있는 제약 회사 아스텔라스 파마(Astellas Pharma Inc.)는 폐경 여성의 중등도에서 중증의 혈관 운동 증상(VMS)을 치료하기 위한 비호르몬성 NK3 수용체 억제제인 Veozah(fezolinetant)에 대해 유럽 위원회로부터 승인을 받았습니다. Veozah는 뇌의 체온 조절 센터에 있는 신경세포를 표적으로 삼아 이러한 증상의 빈도와 강도를 감소시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 갱년기 장애치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 갱년기 장애 치료 시장 : 성장률 분석
- 세계의 갱년기 장애 치료 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 갱년기 장애 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 갱년기 장애 치료 총 시장 규모(TAM)
제6장 시장 세분화
- 세계의 갱년기 장애 치료 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 호르몬 대체 요법(HRT)
- 비호르몬 치료
- 허브 보충제
- 생활 습관 개선
- 세계의 갱년기 장애 치료 시장 : 스테이지별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 갱년기
- 갱년기 후
- 갱년기 전
- 세계의 갱년기 장애 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 안면 홍조
- 땀
- 기분 변화
- 질 건조
- 세계의 갱년기 장애 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타
- 세계의 갱년기 장애 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 전문 클리닉
- 재택 케어
- 기타
- 세계의 갱년기 장애 치료 시장 : 호르몬 보충 요법(HRT) 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 에스트로겐 요법
- 프로게스테론 요법
- 병용 요법
- 경피 패치
- 질 에스트로겐
- 경구용 정제
- 세계의 갱년기 장애 치료 시장 : 비호르몬 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 선택적 에스트로겐 수용체 조절제(SERM)
- 항우울제
- 가바펜틴
- 클로니딘
- 비스포스포네이트
- 칼슘 및 비타민 D 보충제
- 세계의 갱년기 장애 치료 시장 : 허브 보충제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 블랙 코호시
- 레드 클로버
- 동 콰이
- 인삼
- 대두 이소플라본
- 아마씨
- 세계의 갱년기 장애 치료 시장 : 라이프 스타일 개선 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 식습관 변화
- 정기적인 운동
- 스트레스 관리 기술
- 인지행동요법(CBT)
- 금연
- 수면 위생의 실천
제7장 지역별, 국가별 분석
- 세계의 갱년기 장애 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 갱년기 장애 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 갱년기 장애 치료 시장 : 경쟁 구도
- 갱년기 장애 치료 시장 : 기업 프로파일
- Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Bristol-Myers Squibb Company
- Sanofi SA
- AstraZeneca plc
- Eli Lilly and Company
- Novo Nordisk A/S
- Abbott Laboratories
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Ipsen SA
- Dr. Reddy's Laboratories Ltd.
- Theramex
- Besins Healthcare
- Mithra Pharmaceuticals
- Duchesnay USA
- Fervent Pharmaceuticals
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 갱년기 장애 치료 시장(2029년) : 새로운 기회를 제공하는 국가
- 갱년기 장애 치료 시장(2029년) : 새로운 기회를 제공하는 부문
- 갱년기 장애 치료 시장(2029년) : 성장 전략
제36장 부록
HBR
Menopausal disorder treatment encompasses a variety of medical and therapeutic approaches designed to relieve symptoms associated with menopause such as hot flashes, mood fluctuations, sleep issues, and hormonal imbalances aiming to enhance the overall well-being and quality of life for individuals undergoing this transitional phase.
The primary types of menopausal disorder treatments include hormone replacement therapy (HRT), non-hormonal treatments, herbal supplements, and lifestyle changes. Hormone replacement therapy helps regulate hormone levels in women experiencing menopause-related symptoms such as hot flashes, mood swings, and reduced bone density. These treatments are relevant across various stages of the menopausal journey, including perimenopause, menopause, and postmenopause, and are used to address symptoms such as night sweats, mood changes, hot flashes, and vaginal dryness. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels, and are utilized by various end users including hospitals, specialty clinics, home care environments, and more.
The menopausal disorder treatment market research report is one of a series of new reports from The Business Research Company that provides menopausal disorder treatment market statistics, including the menopausal disorder treatment industry's global market size, regional shares, competitors with a menopausal disorder treatment market share, detailed menopausal disorder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the menopausal disorder treatment industry. This menopausal disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The menopausal disorder treatment market size has grown strongly in recent years. It will grow from$10.69 billion in 2024 to $11.50 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to an aging female population, heightened awareness of menopause-related health concerns, a high prevalence of obesity which can worsen menopausal symptoms, increasing acceptance of hormone replacement therapy (HRT), and advancements in personalized medicine.
The menopausal disorder treatment market size is expected to see strong growth in the next few years. It will grow to$15.30 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth anticipated during the forecast period can be attributed to rising healthcare infrastructure spending, a stronger focus on women's health initiatives, increasing collaborations between pharmaceutical companies and research institutions, and growing urbanization leading to lifestyle changes that affect menopausal health. Key trends expected in this period include a shift toward natural and herbal treatment options, the integration of artificial intelligence in treatment planning, the emergence of wearable devices for real-time symptom tracking, an emphasis on holistic wellness programs addressing menopause, and increased investment in women's health startups developing menopause-related solutions.
The growing demand for hormone replacement therapies (HRT) is expected to drive the expansion of the menopausal disorder treatment market. HRT involves the medical process of supplementing or replacing hormones to alleviate the symptoms associated with menopause or hormonal imbalances. The rise in HRT usage is largely fueled by increasing awareness and demand for effective management of menopausal symptoms and hormonal imbalances. HRT addresses menopausal disorders by replenishing estrogen and progesterone levels, helping to restore hormonal balance and alleviate disruptive symptoms such as hot flashes, night sweats, and mood swings, thus improving the quality of life. For example, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based organization offering various support services, reported a 22% increase in HRT prescriptions, reaching 13 million items. Additionally, the number of patients identified for HRT rose by 12%, from 2.3 million in 2022/23 to 2.6 million in 2023/24. This growing demand for hormone replacement therapies is contributing to the growth of the menopausal disorder treatment market.
Leading companies in the menopausal disorder treatment market are developing advanced nonhormonal therapies, such as neurokinin 3 (NK3) receptor antagonist drugs, to effectively manage vasomotor symptoms without the use of hormones. These novel therapies work by blocking NK3 receptors to manage menopausal symptoms, providing an alternative to traditional hormone treatments. For instance, in December 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, received approval from the European Commission for Veozah (fezolinetant), a non-hormonal NK3 receptor antagonist aimed at treating moderate to severe vasomotor symptoms (VMS), including hot flashes and night sweats in menopausal women. Veozah operates by targeting neurons in the brain's temperature regulation center, reducing the frequency and intensity of these symptoms.
In October 2022, Unified Women's Healthcare, a US-based company specializing in comprehensive women's health services, acquired Gennev for an undisclosed amount. This acquisition strengthens Unified Women's Healthcare's position in menopause care in the U.S. by expanding its digital health offerings and improving access to specialized care for women experiencing menopause. Gennev is a US-based digital health platform offering personalized and comprehensive menopause treatment services.
Major players in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., and TherapeuticsMD Inc.
North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in menopausal disorder treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the menopausal disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The menopausal disorder treatment market includes revenues earned by entities providing services such as estrogen-only therapy, combined estrogen and progesterone therapy, bone health management, and hormone level testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The menopausal disorder treatment market also includes sales of hormone replacement therapy (HRT) medications, non-hormonal therapies, dietary supplements, and vaginal estrogen products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Menopausal Disorder Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on menopausal disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for menopausal disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menopausal disorder treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Hormone Replacement Therapy; Non-Hormonal Treatment; Herbal Supplements; Lifestyle Modifications
- 2) By Stages: Menopause; Postmenopause; Perimenopause
- 3) By Application: Hot Flashes; Night Sweats; Mood Swings; Vaginal Dryness
- 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
- 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
- Subsegments:
- 1) By Hormone Replacement Therapy (HRT): Estrogen Therapy; Progesterone Therapy; Combination Therapy; Transdermal Patches; Vaginal Estrogen; Oral Tablets
- 2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs); Antidepressants; Gabapentin; Clonidine; Bisphosphonates; Calcium And Vitamin D Supplements
- 3) By Herbal Supplements: Black Cohosh; Red Clover; Dong Quai; Ginseng; Soy Isoflavones; Flaxseed
- 4) By Lifestyle Modifications: Dietary Changes; Regular Physical Exercise; Stress Management Techniques; Cognitive Behavioral Therapy (CBT); Smoking Cessation; Sleep Hygiene Practices
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co Inc.; Novartis AG; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Menopausal Disorder Treatment Market Characteristics
3. Menopausal Disorder Treatment Market Trends And Strategies
4. Menopausal Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Menopausal Disorder Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Menopausal Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Menopausal Disorder Treatment Market Growth Rate Analysis
- 5.4. Global Menopausal Disorder Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Menopausal Disorder Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Menopausal Disorder Treatment Total Addressable Market (TAM)
6. Menopausal Disorder Treatment Market Segmentation
- 6.1. Global Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormone Replacement Therapy
- Non-Hormonal Treatment
- Herbal Supplements
- Lifestyle Modifications
- 6.2. Global Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Menopause
- Postmenopause
- Perimenopause
- 6.3. Global Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hot Flashes
- Night Sweats
- Mood Swings
- Vaginal Dryness
- 6.4. Global Menopausal Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Other Distribution Channels
- 6.5. Global Menopausal Disorder Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Homecare
- Other End-Users
- 6.6. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Hormone Replacement Therapy (HRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Estrogen Therapy
- Progesterone Therapy
- Combination Therapy
- Transdermal Patches
- Vaginal Estrogen
- Oral Tablets
- 6.7. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Non-Hormonal Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Selective Estrogen Receptor Modulators (SERMs)
- Antidepressants
- Gabapentin
- Clonidine
- Bisphosphonates
- Calcium And Vitamin D Supplements
- 6.8. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Herbal Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Black Cohosh
- Red Clover
- Dong Quai
- Ginseng
- Soy Isoflavones
- Flaxseed
- 6.9. Global Menopausal Disorder Treatment Market, Sub-Segmentation Of Lifestyle Modifications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dietary Changes
- Regular Physical Exercise
- Stress Management Techniques
- Cognitive Behavioral Therapy (CBT)
- Smoking Cessation
- Sleep Hygiene Practices
7. Menopausal Disorder Treatment Market Regional And Country Analysis
- 7.1. Global Menopausal Disorder Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Menopausal Disorder Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Menopausal Disorder Treatment Market
- 8.1. Asia-Pacific Menopausal Disorder Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Menopausal Disorder Treatment Market
- 9.1. China Menopausal Disorder Treatment Market Overview
- 9.2. China Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Menopausal Disorder Treatment Market
- 10.1. India Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Menopausal Disorder Treatment Market
- 11.1. Japan Menopausal Disorder Treatment Market Overview
- 11.2. Japan Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Menopausal Disorder Treatment Market
- 12.1. Australia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Menopausal Disorder Treatment Market
- 13.1. Indonesia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Menopausal Disorder Treatment Market
- 14.1. South Korea Menopausal Disorder Treatment Market Overview
- 14.2. South Korea Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Menopausal Disorder Treatment Market
- 15.1. Western Europe Menopausal Disorder Treatment Market Overview
- 15.2. Western Europe Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Menopausal Disorder Treatment Market
- 16.1. UK Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Menopausal Disorder Treatment Market
- 17.1. Germany Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Menopausal Disorder Treatment Market
- 18.1. France Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Menopausal Disorder Treatment Market
- 19.1. Italy Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Menopausal Disorder Treatment Market
- 20.1. Spain Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Menopausal Disorder Treatment Market
- 21.1. Eastern Europe Menopausal Disorder Treatment Market Overview
- 21.2. Eastern Europe Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Menopausal Disorder Treatment Market
- 22.1. Russia Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Menopausal Disorder Treatment Market
- 23.1. North America Menopausal Disorder Treatment Market Overview
- 23.2. North America Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Menopausal Disorder Treatment Market
- 24.1. USA Menopausal Disorder Treatment Market Overview
- 24.2. USA Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Menopausal Disorder Treatment Market
- 25.1. Canada Menopausal Disorder Treatment Market Overview
- 25.2. Canada Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Menopausal Disorder Treatment Market
- 26.1. South America Menopausal Disorder Treatment Market Overview
- 26.2. South America Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Menopausal Disorder Treatment Market
- 27.1. Brazil Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Menopausal Disorder Treatment Market
- 28.1. Middle East Menopausal Disorder Treatment Market Overview
- 28.2. Middle East Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Menopausal Disorder Treatment Market
- 29.1. Africa Menopausal Disorder Treatment Market Overview
- 29.2. Africa Menopausal Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Menopausal Disorder Treatment Market, Segmentation By Stages, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Menopausal Disorder Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Menopausal Disorder Treatment Market Competitive Landscape And Company Profiles
- 30.1. Menopausal Disorder Treatment Market Competitive Landscape
- 30.2. Menopausal Disorder Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Menopausal Disorder Treatment Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb Company
- 31.2. Sanofi SA
- 31.3. AstraZeneca plc
- 31.4. Eli Lilly and Company
- 31.5. Novo Nordisk A/S
- 31.6. Abbott Laboratories
- 31.7. GlaxoSmithKline plc
- 31.8. Teva Pharmaceutical Industries Ltd.
- 31.9. Ipsen SA
- 31.10. Dr. Reddy's Laboratories Ltd.
- 31.11. Theramex
- 31.12. Besins Healthcare
- 31.13. Mithra Pharmaceuticals
- 31.14. Duchesnay USA
- 31.15. Fervent Pharmaceuticals
32. Global Menopausal Disorder Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Menopausal Disorder Treatment Market
34. Recent Developments In The Menopausal Disorder Treatment Market
35. Menopausal Disorder Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Menopausal Disorder Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Menopausal Disorder Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Menopausal Disorder Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
